Nov 29, 2022 8:50am EST Lexaria’s DehydraTECH-CBD(TM) Enhances Performance Compared to Epidiolex(R) in Seizure Study Program
Nov 01, 2022 9:25am EDT Lexaria Receives Independent Review Board Approval for its Upcoming Human Oral Nicotine Study
